Skip to main content

IB Acquisition Corp.

IBACR
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
SEC CIK
0001998781

No open-market purchases or sales by IB Acquisition Corp. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $660.9K in total; no superinvestor holds it.

Other share classesIBAC

Q4 2024 vs. Q3 2024

How the institutions holding IB Acquisition Corp. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of IBACR: Q3 2024 compared with Q4 2024
MeasureQ3 2024Q4 2024Change
Holders3032+2
Shares8.82M9.32M+503.6K (+5.7%)
Value$691.1K$631.1K−$60.0K (−8.7%)

New holders (6)

Institutions that held IB Acquisition Corp. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to IBACR in Q4 2024
InstitutionSharesValue% of portfolio
Toronto Dominion Bank612,000$33.7K0.00%
Decagon Asset Management LLP454,915$31.5K0.01%
Harraden Circle Investments, LLC100,000$6.93K0.01%
Flow Traders U.S. LLC23,369$2.00K0.00%
Susquehanna International Group, LLP26,653$1.85K0.00%
Two Sigma Securities, LLC12,946$8970.00%

Sold out (4)

Institutions that held IB Acquisition Corp. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of IBACR in Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Cowen and Company, LLC625,299$43.8K
Walleye Capital LLC64,000$4.49K
Walleye Trading LLC36,000$2.52K
UBS Group AG449$38